Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
42,28 USD | -4,24 % |
|
+7,56 % | +219,85 % |
Métier
Nombre d'employés: 143
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Jason Rhodes
FOU | Founder | 54 | 01/12/17 |
Rick Scalzo
DFI | Director of Finance/CFO | 38 | 01/12/19 |
John Najim
CTO | Chief Tech/Sci/R&D Officer | 48 | 01/08/19 |
Chief Tech/Sci/R&D Officer | 63 | 27/01/20 | |
Chief Tech/Sci/R&D Officer | 61 | 28/06/19 | |
Wildon Farwell
CTO | Chief Tech/Sci/R&D Officer | 49 | 04/03/21 |
Ashish Dugar
CTO | Chief Tech/Sci/R&D Officer | - | 08/02/21 |
Susanna High
COO | Chief Operating Officer | 56 | 01/07/20 |
Amy Reilly
IRC | Investor Relations Contact | 51 | 01/07/20 |
Daniel Wilson
LAW | General Counsel | 53 | 01/06/20 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Edward Hurwitz
BRD | Director/Board Member | 60 | 01/11/18 |
David Lubner
BRD | Director/Board Member | 60 | 01/03/20 |
Dirk Kersten
BRD | Director/Board Member | 49 | 01/11/18 |
Jason Rhodes
FOU | Founder | 54 | 01/12/17 |
Carlo Incerti
BRD | Director/Board Member | 65 | 02/03/22 |
Chief Tech/Sci/R&D Officer | 61 | 28/06/19 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 99 164 649 | 98 767 534 ( 99,60 %) | 0 | 99,60 % |
Coordonnées société
![Adresse Dyne Therapeutics, Inc.(DYN)](https://cdn.zonebourse.com/static/address/112544281.png)
Secteur
![Consensus](/images/consensus_flch.gif)
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+219,85 % | 4,38 Md | |
+21,79 % | 47,96 Md | |
+0,76 % | 42,45 Md | |
+43,96 % | 41,47 Md | |
+26,43 % | 31,6 Md | |
+20,90 % | 28,63 Md | |
-4,47 % | 28,03 Md | |
+52,01 % | 14,56 Md | |
+45,20 % | 14,14 Md | |
+2,84 % | 12,58 Md |
- Bourse
- Actions
- Action DYN
- Société Dyne Therapeutics, Inc.